Press release
9 December, 2009
Oriflame Cosmetics agrees ¤400m
Refinancing of Debt
Oriflame Cosmetics S.A. today signed a ¤400m three-year Term Loan and
Revolving Credit Facility (the "Facility") with its core relationship
banks.
The Facility will be used for general corporate purposes and will
refinance Oriflame's existing credit facilities of ¤375m (signed
April 2006) and ¤130m (signed February 2009).
"With support of our core banks, Oriflame has with this facility
secured its long-term financing. We now have the necessary financing
in place for strategic purposes and to support our continued growth",
Gabriel Bennet, CFO at Oriflame Cosmetics S.A., comments.
The Facility is co-ordinated by Nordea and SEB, who also acted as
Bookrunners. DnB NOR ASA (Sweden Branch), ING and The Royal Bank of
Scotland plc joined as Mandated Lead Arrangers. The Facility was
increased after a substantial oversubscription. The following banks
joined the Facility:
Nordea, Bookrunner
SEB, Bookrunner
DnB NOR ASA, Sweden Branch, Mandated Lead Arranger
ING, Mandated Lead Arranger
The Royal Bank of Scotland plc, Mandated Lead Arranger
Raiffeisen Zentralbank Österreich Aktiengesellschaft, Arranger
HSBC Bank plc, Arranger
For additional information, please contact:
Gabriel Bennet,
CFO +41 798
263 713
Patrik Linzenbold, Sen. Director IR
+46 765 42 27 09
Micael Ljunggren, SEB
+46 70 772 32 17
Jonas B. Lind, Nordea
+46 70 666 29 82
Oriflame Cosmetics is an international beauty company selling direct.
The company began operations in 1967 in Sweden and has today a
presence in 62 countries worldwide. Oriflame offers a wide portfolio
of Swedish, natural, innovative, quality beauty products at
affordable prices. To-date Oriflame has over 3.0 million consultants
worldwide with annual sales of ¤1.3 billion. Oriflame offers the
leading business opportunity for people who want to start making
money the same day they join and then grow into a leadership role and
fulfil their personal dreams and ambitions. Oriflame is listed on
NASDAQ OMX Stockholm since 2004.
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.